Literature DB >> 25118613

Septic complications and hospital admissions after transrectal ultrasound-guided prostate biopsy: incidence rates and outcomes in 913 consecutive biopsies.

Branimir Lodeta1, Vladimir Trkulja.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25118613     DOI: 10.1007/s11255-014-0815-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  8 in total

1.  EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

Authors:  Axel Heidenreich; Patrick J Bastian; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Theodor van der Kwast; Malcolm Mason; Vsevolod Matveev; Thomas Wiegel; F Zattoni; Nicolas Mottet
Journal:  Eur Urol       Date:  2013-10-06       Impact factor: 20.096

2.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Authors:  Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

3.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

Review 4.  Pharmacokinetics and pharmacodynamics of fluoroquinolones.

Authors:  J Turnidge
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.

Authors:  René Raaijmakers; Wim J Kirkels; Monique J Roobol; Mark F Wildhagen; Fritz H Schrder
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

6.  Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.

Authors:  Osama M Zaytoun; Ethan H Vargo; Ramanathan Rajan; Ryan Berglund; Steven Gordon; J Stephen Jones
Journal:  Urology       Date:  2011-03-21       Impact factor: 2.649

7.  Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy.

Authors:  Jong Beom Kim; Seung Il Jung; Eu Chang Hwang; Dong Deuk Kwon
Journal:  Korean J Urol       Date:  2014-03-13

8.  Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

Authors:  Derek J Rosario; J Athene Lane; Chris Metcalfe; Jenny L Donovan; Andy Doble; Louise Goodwin; Michael Davis; James W F Catto; Kerry Avery; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2012-01-09
  8 in total
  4 in total

1.  Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy.

Authors:  Xue-Fei Ding; Yang Luan; Sheng-Ming Lu; Guang-Chen Zhou; Tian-Bao Huang; Liang-Yong Zhu; Cheng-Hao Guo
Journal:  World J Urol       Date:  2020-09-19       Impact factor: 4.226

2.  Infection prevention and ultrasound probe decontamination practices in Europe: a survey of the European Society of Radiology.

Authors:  Christiane Marita Nyhsen; Hilary Humphreys; Carlos Nicolau; Gerhard Mostbeck; Michel Claudon
Journal:  Insights Imaging       Date:  2016-10-24

3.  Infection prevention and control in ultrasound - best practice recommendations from the European Society of Radiology Ultrasound Working Group.

Authors:  Christiane M Nyhsen; Hilary Humphreys; Roland J Koerner; Nicolas Grenier; Adrian Brady; Paul Sidhu; Carlos Nicolau; Gerhard Mostbeck; Mirko D'Onofrio; Afshin Gangi; Michel Claudon
Journal:  Insights Imaging       Date:  2017-11-27

Review 4.  Strategies for prevention of ultrasound-guided prostate biopsy infections.

Authors:  Diane D Lu; Jay D Raman
Journal:  Infect Drug Resist       Date:  2016-07-08       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.